REGN

REGN

Regeneron Pharmaceuticals Inc
Biotechnology
$748.87 -2.48% As of Apr 13, 1:44 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

REGN Enters Squeeze Mode at $748.87

Neutral
Apr 13, 2026 at 1:44 AM • $748.87 (-2.48%)

Regeneron Pharmaceuticals Inc (REGN) closed down 2.48% at $748.87 on April 13.

From a technical standpoint, the outlook appears mixed:

Moving Averages Mixed signals with price near the 9-day EMA ($760.69). The 21-day EMA sits at $759.83.
Momentum RSI at 46.1 is in neutral territory but trending lower. MACD is bullish (-0.13 vs signal -1.59).
Volatility Stock has been in a TTM Squeeze for 20 days, indicating compressed volatility and potential for a significant move.

Traders are watching $727.50 on the downside and $779.99 on the upside.

Calm Before Storm? REGN Squeezes at $748.87

Neutral
Apr 12, 2026 at 2:24 AM • $748.87 (-2.48%)

REGN Tightening Range Signals Pending Move at $748.87

Neutral
Apr 11, 2026 at 5:08 AM • $748.87 (-2.48%)

TTM Squeeze Tightens Grip on REGN at $748.87

Neutral
Apr 10, 2026 at 9:01 PM • $748.87 (-2.48%)

Squeeze Play: REGN Preps for Breakout at $767.85

Neutral
Apr 9, 2026 at 9:01 PM • $767.85 (-0.99%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $748.87
Daily Change -2.48%
Sentiment Neutral
Sector Biotechnology
Last Updated Apr 13

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.